The present study has been undertaken to investigate plasma creatinine, folate and vitamin B 12 as underlying factors in the reduction of plasma homocysteine concentration in different trimesters of pregnancy. Under a cross-sectional design, 30 healthy nonpregnant as well as 130 pregnant women, at 3 different trimesters of pregnancy (43 in 1 st trimester, 44 in 2 nd trimester and 43 in 3 rd trimester) were sampled for plasma levels of folate, vitamin B 12, homocysteine and creatinine. Plasma homocysteine and creatinine level were significantly (p<0.014) lower in pregnant women at different trimester (1 st , 2 nd and 3 rd trimester) compared to nonpregnant women. Plasma folate was significantly higher in different groups of pregnant women compared to nonpregnant women. Significant negative correlation was found between plasma homocysteine and folate in nonpregnant (r=-0.453, p<0.012) and pregnant women at 2 nd trimester (r=-0.681, p<0.001). There was found significant negative correlation between plasma homocysteine and vitamin B 12 at 1 st trimester group (r=-0.322, p<0.035) and 2 nd trimester group (r=-0.394, p<0.008) but not in 3 rd trimester. In present study, reduction of plasma total homocysteine appears to be a physiological response in pregnancy, and the level of plasma folate and vitamin B 12 , but can not be explained by renal homodynamic changes.
Abstract:
The present study has been undertaken to investigate plasma creatinine, folate and vitamin B 12 as underlying factors in the reduction of plasma homocysteine concentration in different trimesters of pregnancy. Under a cross-sectional design, 30 healthy nonpregnant as well as 130 pregnant women, at 3 different trimesters of pregnancy (43 in 1 st trimester, 44 in 2 nd trimester and 43 in 3 rd trimester) were sampled for plasma levels of folate, vitamin B 12, homocysteine and creatinine. Plasma homocysteine and creatinine level were significantly (p<0.014) lower in pregnant women at different trimester (1 st , 2 nd and 3 rd trimester) compared to nonpregnant women. Plasma folate was significantly higher in different groups of pregnant women compared to nonpregnant women. Significant negative correlation was found between plasma homocysteine and folate in nonpregnant (r=-0.453, p<0.012) and pregnant women at 2 nd trimester (r=-0.681, p<0.001). There was found significant negative correlation between plasma homocysteine and vitamin B 12 at 1 st trimester group (r=-0.322, p<0.035) and 2 nd trimester group (r=-0.394, p<0.008) but not in 3 rd trimester. In present study, reduction of plasma total homocysteine appears to be a physiological response in pregnancy, and the level of plasma folate and vitamin B 12 , but can not be explained by renal homodynamic changes.
Key words: Folate, vitamin B 12 , homocysteine and pregnancy Introduction: An elevated plasma total homocysteine (tHcy) concentration is regarded as a risk factor for atherosclerosis 1, 2 and venous thrombosis 3 . Serious pregnancy complications, including pregnancy-induced hypertension, preeclampsia 4 , placental abruption 5 and spontaneous abortion 5, 6 and adverse pregnancy outcomes such as neural tube defects 7 and low birth weight 8 are associated with elevated homocysteine concentration. In normal pregnancy homocysteine concentration in plasma will decrease. THcy concentrations were 29-60% lower in pregnant women than in non pregnant women and reached their lowest values during the second trimester of pregnancy 9, 10 which is consistent with other previous findings 9, 10 . Various hypotheses explaining the decrease in tHcy concentration during pregnancy have been proposed, among these are hormonal influences on homocysteine metabolism 12, 13 , maternal dietary protein intake during pregnancy 12 , pregnancy-associated hemodilution 9, 10, 13 , or fetal utilization 9, 13, 14 . Murphy et al.2002 11 demonstrated that the reduction of tHcy can not be accounted for by folate supplementations, plasma volume expansion, or a decrease in serum albumin. They suggested that low tHcy represents a physiologic adaptation to pregnancy, mediated by endocrine changes. An alternative mechanism for the pregnancy-related decrease in total plasma homocysteine concentration is the change in renal hemodynamics during pregnancy, glomerular filtration rate (GFR) and renal plasma flow increase markedly in pregnancy 15, 16 . Homocysteine derived from the demethylation of the amino acid methonine, is either further catabolished by trans-sulfuration to cysteine or remethylation to methonine. Remethylation of methonine requires the cofactors, folate and vitamin B 12 . The concentration of homocysteine is regulated by many factors such as age, genetically determined metabolic enzyme alteration, nutritional factors like Vitamin B 6 , B 12 and folate. Folate is essential to maintain the normal levels of serum homocysteine. Folate plays an important role in two biochemical cycles; one involving DNA biosynthesis and in one carbon metabolism such as DNA, lipid and protein methylation 17 , so the requirement of folate during pregnancy is increased. Folate in pregnancy, protects against a number of congenital malformations including neural tube defects 18 , low birth weight, recurrent miscarriage, placental abruption and intrauterine growth restriction 19 . Vitamin B 12 is an essential nutrient in the diet of humans due to its important function as a co-enzyme in the remethylation of homocysteine to methionine and in the conversion of methylemalonyl CoA to succynyl CoA.
Objective:
This study was conducted to compare the folate, vitamin B 12 and homocysteine status in pregnant and nonpregnant women and to investigate the dynamics of plasma homcysteine changes in pregnancy and its underlying causes.
Subjects and Methods:
Subjects: The study was approved by the Biomedical Research Group, and consent was obtained from each participant on recruitment. Healthy pregnant women (n=43 in 1 st trimester, n=44 in 2 nd trimester and n=43 in 3 rd trimester, 18 to 35 years old) and nonpregnant women (n=30, 18 to 35 years old) were sampled. Pregnant women attending antenatal clinics at the BSMMU and Shurwardy hospital were recruited in the study during antenatal visit at 6-12 week, 13-24 week and 25-36 week of gestation, and the study was conducted as cross-sectional design. Age matched nonpregnant women were recruited as control from the staff of Biomedical Research Group, BIRDEM and the graduate students of Dhaka University. Trained interviewer collected information on socioeconomic data, previous obstetric history, vitamin supplementation (either folate or multivitamin), and height and weight.
Sample Collection and Analytical Methods:
Venous blood sample were drawn from antecubital vein. Fasting blood sample were collected in a haperiniazed test tube. Blood was allowed to stand for 10 minutes and then centrifuged for 10 minutes at a rate of 3000 rpm at 4 
STATISTICAL ANALYSIS
Data are expressed as median (range) for non-parametric values. Comparison between groups were done using Mann-Whitney U test for skewed data. The relationship between homocysteine and other variables were examined using Spearmen's nonparametric coefficient correlation analysis. Plasma vitamin concentrations were compared with published reference values to determine the proportions of nonpregnant and pregnant groups with biochemical evidence of vitamin deficiencies. Vitamin deficiency was defined as plasma concentrations < 6.8 nmol/l (3 ng/ml) for folate 24 and < 258 pmol/l (350 pg/ml) for vitamin B 12 25, 26 . There is no standard definition of elevated Hcy, but Ronnenberg et al. 27 defined it as a plasma concentration of Hcy above the 90th percentile among women. In this study we defined elevated Hcy as a plasma concentration of >12.61µ mole/l. A p value of <0.05 was considered as significant. All the statistical analysis were performed with the SPSS data (SPSS Inc, Chicago, IL, USA). 12 and creatinine of nonpregnant and pregnmant women (all trimester combined) revealed a significant negative correlation between plasma homocysteine and folate in both pregnant women (r= -0.327, p<0.001) and nonpregnant women (r = -0.453, p<0.012). There was also found a Significant positive correlation (r= 0.276, p<0.001), between plasma homocysteine and creatinine in pregnant women, but no such correlation was found in nonpregnant women. It is to be noted that plasma homocysteine was not found to be correlated significantly with plasma vitamin B 12 either in case of pregnant or nonpregnant women. Table-4 depicts the spearmans nonparametic correlation coefficient (r) of plasma homocysteine with plasma folate, vitamin B 12 and creatinine of nonpregnant women and pregnmant women in different trimester. There was found a significant negative correlation (r=-0.453, p<0.012) between homocysteine and folate in nonpregnant women. Similar correlation (r= -0.681, p<0.001) was found to exist between homocysteine and folate in pregnant women belonging to 2 nd trimester. A significant negative correlation was found to exist between plasma homocysteine and vitamin B 12 in pregnant women at 1st trimester (r= -0.322, p<0.035) and 2nd trimester (r= -0.394, p< 0.044). A significant positive correlation (r= 0.37, p<0.015) was found to exist between plasma homocysteine and creatinine in pregnant women at 1 st trimester. Spearman's nonparametric correlation coefficient are performed for the analysis; p<0.05 are considered as statistically significant; n= Number of subjects;. 
RESULTS

Discussion:
In the present study pregnant women have been found to have lower levels of plasma tHcy, and the lowest values was found in 2 nd trimester of pregnancy which is consistent with previous findings 9, 10 which reported that tHcy concentrations were 29-60% lower in pregnant women than in nonpregnant women and reached their lowest values during the second trimester of pregnancy. However, Murphy et al. (2002) 11 has shown that tHcy concentration decreased gradually up to 32 weeks of pregnancy with no further decrease onwards. The present data, however, are in partial conformity with the longitudinal data Cikot et al 13 and also with that of Rolf et al. 28 , which reported only a slight reduction in tHcy concentration during early pregnancy and no further decrease throughout mid-to-late pregnancy. It is interesting to note that tHcy concentration in plasma actually decreases in normal pregnancy. Various hypotheses have been proposed to explaining the decrease in tHcy concentration during pregnancy. Among these are hormonal influences on tHcy metabolism 12, 13 , maternal dietary protein intake during pregnancy 12 , pregnancy-associated hemodilution 9, 10, 13 , or fetal utilization 9, 13, 14 .
In the present study plasma creatinine concentration is significantly lower in different groups of pregnant women than in nonpregnant women. This finding is similar to that of Murphy et al. 11 , who reported that plasma tHcy and creatinine concentrations parallely decreases from preconception to pregnancy in the same group of women. The result suggested that the magnitude of the corresponding reductions in tHcy during pregnancy are considerably greater than the changes in serum creatinine, a marker of renal function. Similar reduction is also found in the present study where plasma creatinine concentration decreased to 4.8%, 11.5% and 18.25% at 1st, 2nd and 3rd trimester groups respectively, and the magnitude of the corresponding reduction in tHcy are 32.23%, 45.48% and 45.16%, which are considerably greater than the change in plasma creatinine. Lower tHcy concentrations observed during pregnancy due to dilution resulting from the expansion in blood volume. The increase in gestational blood volume begins at 6 to 10 weeks, proceeds rapidly during the second trimester, and peaks at 30 to 34 weeks-the average total increase is 1.2 to 1.5 L 29, 30 . In the present study plasma folate is significantly higher in pregnant women in all trimester (1 st , 2 nd and 3 rd trimester) as compared to nonpregnant women. Several previous studies reported that serum folate concentration slightly decreases during pregnancy, with recovery after delivery 28, 31, 32 . A significant negative correlation between plasma tHcy and folate levels were found in nonpregnant (r=-0.453, p<0.012) as well as in pregnant groups (r= -0.327, p<0.001) and this is in agreement with previous findings 10, 33 . There may be two reasons for the observed increase of folate concentration in the present study: one may be dietary intake, another may be folate supplementation in pregnancy. When folate supplementation is considered, significantly (p<0.001) higher concentration of folate is found in supplemented women at different trimesters of pregnant women as compared to unsupplemented women. Plasma tHcy concentration is significantly lower in vitamin-supplemented group compared to unsupplemented group in the 2nd trimester (p < 0.002). In unsupplemented group tHcy concentration is lower throughout pregnancy. Murphy et al. 11 also shown that tHcy concentration gradually decline through out pregnancy from 1 st trimester to 3 rd trimester in both supplemented and unsupplemented group . Thus it can be hypothesized that lower tHcy concentration in unsupplemented group due to physiologically induced reduction in pregnancy, which is independent to folate supplementation. Alternately, the observed value of plasma folate in the unsupplemented group may be sufficient to have a physiological response of tHcy in pregnancy.
In the present study plasma vitamin B 12 level is lower in all trimesters of pregnancy compared to nonpregnant group and the data are supported by a previous study 32 . Although significant negative correlation between tHcy and vitamin B 12 is found in 1st trimester group (r= -0.322, p<0.035) and 2nd trimester group(r= -0.394, p<0.008), but no significant difference is found in whole pregnancy (r = -0.128, p<0.146) and it also supported the previous study by Park et al. 33 , where marginal negative correlation (r= -0.26, p<0.06) between tHcy and vitamin B 12 levels have been found among pregnant women. In conclusion present study indicate, the reduction of plasma total homocysteine is a physiological response in pregnancy and the level of plasma folate and vitamin B 12 , but can not be explained by renal hemoidynamic changes.
